241 related articles for article (PubMed ID: 17717437)
41. A subset of prostate basal cells lacks the expression of corresponding phenotypic markers.
Man YG; Zhao C; Chen X
Pathol Res Pract; 2006; 202(9):651-62. PubMed ID: 16842934
[TBL] [Abstract][Full Text] [Related]
42. Adenomyoepithelial tumours and myoepithelial carcinomas of the breast--a spectrum of monophasic and biphasic tumours dominated by immature myoepithelial cells.
Hungermann D; Buerger H; Oehlschlegel C; Herbst H; Boecker W
BMC Cancer; 2005 Jul; 5():92. PubMed ID: 16050957
[TBL] [Abstract][Full Text] [Related]
43. The expression of p63 and cytokeratin 5 in mixed tumors of the canine mammary gland provides new insights into the histogenesis of these neoplasms.
Ramalho LN; Ribeiro-Silva A; Cassali GD; Zucoloto S
Vet Pathol; 2006 Jul; 43(4):424-9. PubMed ID: 16846983
[TBL] [Abstract][Full Text] [Related]
44. Basoluminal carcinoma: a new biologically and prognostically distinct entity between basal and luminal breast cancer.
Laakso M; Tanner M; Nilsson J; Wiklund T; Erikstein B; Kellokumpu-Lehtinen P; Malmström P; Wilking N; Bergh J; Isola J
Clin Cancer Res; 2006 Jul; 12(14 Pt 1):4185-91. PubMed ID: 16857790
[TBL] [Abstract][Full Text] [Related]
45. Poor prognosis in breast carcinomas correlates with increased expression of targetable CD146 and c-Met and with proteomic basal-like phenotype.
Garcia S; Dalès JP; Charafe-Jauffret E; Carpentier-Meunier S; Andrac-Meyer L; Jacquemier J; Andonian C; Lavaut MN; Allasia C; Bonnier P; Charpin C
Hum Pathol; 2007 Jun; 38(6):830-41. PubMed ID: 17316758
[TBL] [Abstract][Full Text] [Related]
46. Expression of the neuroendocrine phenotype in carcinomas of the breast.
Sapino A; Righi L; Cassoni P; Papotti M; Pietribiasi F; Bussolati G
Semin Diagn Pathol; 2000 May; 17(2):127-37. PubMed ID: 10839613
[TBL] [Abstract][Full Text] [Related]
47. Breast carcinoma with basal differentiation: a proposal for pathology definition based on basal cytokeratin expression.
Rakha EA; El-Sayed ME; Green AR; Paish EC; Lee AH; Ellis IO
Histopathology; 2007 Mar; 50(4):434-8. PubMed ID: 17448018
[TBL] [Abstract][Full Text] [Related]
48. Myoepithelial cells: pathology, cell separation and markers of myoepithelial differentiation.
Clarke C; Sandle J; Lakhani SR
J Mammary Gland Biol Neoplasia; 2005 Jul; 10(3):273-80. PubMed ID: 16807806
[TBL] [Abstract][Full Text] [Related]
49. Human mammary luminal epithelial cells contain progenitors to myoepithelial cells.
Péchoux C; Gudjonsson T; Ronnov-Jessen L; Bissell MJ; Petersen OW
Dev Biol; 1999 Feb; 206(1):88-99. PubMed ID: 9918697
[TBL] [Abstract][Full Text] [Related]
50. Demystifying basal-like breast carcinomas.
Da Silva L; Clarke C; Lakhani SR
J Clin Pathol; 2007 Dec; 60(12):1328-32. PubMed ID: 17496191
[TBL] [Abstract][Full Text] [Related]
51. Molecular classification of breast carcinomas with particular emphasis on "basal-like" carcinoma: a critical review.
Lavasani MA; Moinfar F
J Biophotonics; 2012 Apr; 5(4):345-66. PubMed ID: 22232077
[TBL] [Abstract][Full Text] [Related]
52. Adhesion molecules in breast cancer: role of alpha 2 beta 1 integrin.
Alford D; Pitha-Rowe P; Taylor-Papadimitriou J
Biochem Soc Symp; 1998; 63():245-59. PubMed ID: 9513728
[TBL] [Abstract][Full Text] [Related]
53. Extensive extranodal metastases of basal-like breast cancer with predominant myoepithelial spindle cell differentiation.
Trepp R; Padberg BC; Varga Z; Cathomas R; Inauen R; Reinhart WH
Pathol Res Pract; 2010 May; 206(5):334-7. PubMed ID: 19616899
[TBL] [Abstract][Full Text] [Related]
54. Comparative microRNA profiling of sporadic and BRCA1 associated basal-like breast cancers.
Yan M; Shield-Artin K; Byrne D; Deb S; Waddell N; ; Haviv I; Fox SB
BMC Cancer; 2015 Jul; 15():506. PubMed ID: 26152113
[TBL] [Abstract][Full Text] [Related]
55. Aurora-A gene is frequently amplified in basal-like breast cancer.
Staff S; Isola J; Jumppanen M; Tanner M
Oncol Rep; 2010 Feb; 23(2):307-12. PubMed ID: 20043089
[TBL] [Abstract][Full Text] [Related]
56. Cytokeratins 7 and 14 in special types of invasive breast carcinomas.
Toth T
Med Pregl; 1999; 52(6-8):227-32. PubMed ID: 10518377
[TBL] [Abstract][Full Text] [Related]
57. Ultrastructure of medullary, intraductal, tubular and adenocystic breast carcinomas: comparative patterns of myoepithelial differentiation and basal lamina deposition.
Gould VE; Miller J; Jao W
Am J Pathol; 1975 Mar; 78(3):401-8. PubMed ID: 164121
[TBL] [Abstract][Full Text] [Related]
58. Abnormalities of the inactive X chromosome are a common feature of BRCA1 mutant and sporadic basal-like breast cancer.
Ganesan S; Richardson AL; Wang ZC; Iglehart JD; Miron A; Feunteun J; Silver D; Livingston DM
Cold Spring Harb Symp Quant Biol; 2005; 70():93-7. PubMed ID: 16869742
[TBL] [Abstract][Full Text] [Related]
59. 2-DE analysis of a new human cell line EM-G3 derived from breast cancer progenitor cells and comparison with normal mammary epithelial cells.
Selicharová I; Smutná K; Sanda M; Ubik K; Matousková E; Bursíková E; Brozová M; Vydra J; Jirácek J
Proteomics; 2007 May; 7(9):1549-59. PubMed ID: 17366476
[TBL] [Abstract][Full Text] [Related]
60. Establishment, growth and in vivo differentiation of a new clonal human cell line, EM-G3, derived from breast cancer progenitors.
Brozova M; Kleibl Z; Netikova I; Sevcik J; Scholzova E; Brezinova J; Chaloupkova A; Vesely P; Dundr P; Zadinova M; Krasna L; Matouskova E
Breast Cancer Res Treat; 2007 Jun; 103(2):247-57. PubMed ID: 17063277
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
